MWNA
BIIB icon

Marshall Wace North America’s Biogen BIIB Stock Holding History

Marshall Wace North America’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.66M Sell
5,876
-154,056
-96% -$50.5M 0.01% 774
2021
Q2 		$55.4M Sell
159,932
-20,267
-11% -$6.14M 0.23% 91
2021
Q1 		$50.4M Sell
180,199
-182,683
-50% -$49.3M 0.21% 116
2020
Q4 		$88.9M Buy
362,882
+221,548
+157% +$57.2M 0.4% 50
2020
Q3 		$40.1M Buy
141,334
+139,527
+7,721% +$38.9M 0.26% 97
2020
Q2 		$483K Sell
1,807
-102,350
-98% -$30.8M ﹤0.01% 929
2020
Q1 		$33M Sell
104,157
-11,035
-10% -$3.35M 0.25% 114
2019
Q4 		$34.2M Buy
+115,192
New +$32M 0.16% 152
2019
Q1 		– Sell
-23,179
Closed -$6.97M – 1563
2018
Q4 		$6.97M Sell
23,179
-183,589
-89% -$58.6M 0.07% 202
2018
Q3 		$73.1M Buy
+206,768
New +$71.2M 0.5% 51
2018
Q2 		– Sell
-100,027
Closed -$27.4M – 1395
2018
Q1 		$27.4M Sell
100,027
-155,971
-61% -$48.4M 0.14% 169
2017
Q4 		$81.6M Buy
255,998
+16,582
+7% +$5.32M 0.45% 44
2017
Q3 		$74.9M Sell
239,416
-14,608
-6% -$4.33M 0.47% 33
2017
Q2 		$68.8M Buy
254,024
+113,315
+81% +$30M 0.5% 39
2017
Q1 		$38.4M Buy
+140,709
New +$39.8M 0.3% 93
2013
Q4 		$7.97M Buy
+28,487
New +$7.37M 0.17% 141

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace North America's BIIB Position: Q3 2021 in Review

Marshall Wace North America reduced its Biogen (BIIB) stake by 96% in Q3 2021, selling an estimated $50.5M and leaving 5,876 shares worth $1.66M. The position accounts for 0.01% of the portfolio, ranked #774.

Marshall Wace North America first reported a position in BIIB in Q4 2013 and has held it in 16 quarters since. The position peaked at $88.9M in Q4 2020. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Marshall Wace North America held 5,876 shares of Biogen worth $1.66M as of Q3 2021.
  • Marshall Wace North America sold 154,056 Biogen shares in Q3 2021, an estimated $50.5M.
  • Biogen made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #774 holding.
  • Marshall Wace North America first reported a position in Biogen in Q4 2013 and has held it in 16 quarters since.
  • Marshall Wace North America's Biogen position peaked at $88.9M in Q4 2020.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.